(Hypertension. 2002;39:609.)
© 2002 American Heart Association, Inc.
Scientific Contributions |
From the Max Delbrück Center for Molecular Medicine and Franz Volhard Clinic HELIOS Kliniken-Berlin, Medical Faculty of the Charité, Humboldt University of Berlin (B.L., E. B.-S., H.H., E.K., J.T., F.C.L., M.G., W.-H.S.); the New York Medical College (M.H.-W., M.L.S.), Valhalla, NY; and the Department of Internal Medicine-Nephrology, Hannover Medical School (H.H.), Hannover, Germany
Correspondence to Wolf-Hagen Schunck, Max Delbrück Center for Molecular Medicine, Robert-Rössle-Str 10, 13092 Berlin, Germany. E-mail schunck{at}mdc-berlin.de
P450-dependent arachidonic acid (AA) metabolites regulate arterial tone by modulating calcium-activated (BK) potassium channels in vascular smooth muscle cells (VSMC). Because eicosapentaenoic acid (EPA) has been reported to improve vascular function, we tested the hypothesis that P450-dependent epoxygenation of EPA produces alternative vasoactive compounds. We synthesized the 5 regioisomeric epoxyeicosattrienoic acids (EETeTr) and examined them for effects on K+ currents in rat cerebral artery VSMCs with the patch-clamp technique. 11(R),12(S)-epoxyeicosatrienoic acid (50 nmol/L) was used for comparison and stimulated K+ currents 6-fold at +60 mV. However, 17(R),18(S)-EETeTr elicited a more than 14-fold increase. 17(S),18(R)-EET and the remaining four regioisomers were inactive. The effect of 17(R),18(S)-EETeTr was blocked by tetraethylammonium but not by 4-aminopyridine. VSMCs expressed P450s 4A1 and 4A3. Recombinant P450 4A1 hydroxylated EPA at C-19 and C-20 and epoxygenated the 17,18-double bond, yielding the R, S- and S, R-enantiomers in a ratio of 64:36. We conclude that 17(R),18(S)-EETeTr represents a novel, potent activator of BK potassium channels. Furthermore, this metabolite can be directly produced in VSMCs. We suggest that 17(R),18(S)-EETeTr may function as an important hyperpolarizing factor, particularly with EPA-rich diets.
Key Words: vascular smooth muscle cells endothelium-derived factors potassium channels cytochrome P450
This article has been cited by other articles:
![]() |
A. A. Spector Arachidonic acid cytochrome P450 epoxygenase pathway J. Lipid Res., April 1, 2009; 50(Supplement): S52 - S56. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Morin, M. Sirois, V. Echave, E. Rizcallah, and E. Rousseau Relaxing effects of 17(18)-EpETE on arterial and airway smooth muscles in human lung Am J Physiol Lung Cell Mol Physiol, January 1, 2009; 296(1): L130 - L139. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. L. Hall, K. A. Sanders, T. A. B. Sanders, and P. J. Chowienczyk A High-Fat Meal Enriched with Eicosapentaenoic Acid Reduces Postprandial Arterial Stiffness Measured by Digital Volume Pulse Analysis in Healthy Men J. Nutr., February 1, 2008; 138(2): 287 - 291. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Hercule, B. Salanova, K. Essin, H. Honeck, J. R. Falck, M. Sausbier, P. Ruth, W.-H. Schunck, F. C. Luft, and M. Gollasch Vascular: The vasodilator 17,18-epoxyeicosatetraenoic acid targets the pore-forming BK {alpha} channel subunit in rodents Exp Physiol, November 1, 2007; 92(6): 1067 - 1076. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Spector and A. W. Norris Action of epoxyeicosatrienoic acids on cellular function Am J Physiol Cell Physiol, March 1, 2007; 292(3): C996 - C1012. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. B. Campbell, B. B. Holmes, J. R. Falck, J. H. Capdevila, and K. M. Gauthier Regulation of potassium channels in coronary smooth muscle by adenoviral expression of cytochrome P-450 epoxygenase Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H64 - H71. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. Muller, J. Theuer, E. Shagdarsuren, E. Kaergel, H. Honeck, J.-K. Park, M. Markovic, E. Barbosa-Sicard, R. Dechend, M. Wellner, et al. A Peroxisome Proliferator-Activated Receptor-{alpha} Activator Induces Renal CYP2C23 Activity and Protects from Angiotensin II-Induced Renal Injury Am. J. Pathol., February 1, 2004; 164(2): 521 - 532. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |